Search research articles
Contact Us
Filters
Showing results (21-30 of 245) with videos related to
Page
of 25
Sort By:
Science (New York, N.Y.)
|
May 14, 1993
Funding for gene therapy
B A Chabner, R Levy
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1991
Reversal of multidrug resistance
B A Chabner, W Wilson
Cancer Treatment Reports
|
July 1, 1977
Role of drug concentration, duration of exposure, and endogenous metabolites in determining methotrexate cytotoxicity
H M Pinedo, B A Chabner
Cancer Research
|
March 1, 1978
Pyrimidine nucleoside monophosphate kinase from human leukemic blast cells
K R Hande, B A Chabner
Analytical Biochemistry
|
January 1, 1980
A competitive protein binding assay for allopurinol and oxipurinol
K R Hande, B A Chabner
NCI Monographs : a Publication of the National Cancer Institute
|
January 1, 1986
National Institutes of Health Consensus Development Conference on Adjuvant Chemotherapy and Endocrine Therapy for Breast Cancer. Editorial overview
M E Lippman, B A Chabner
The New England Journal of Medicine
|
February 20, 1992
Progress against rare and not-so-rare cancers
B A Chabner, M A Friedman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2001
On receptor inhibitors and chemotherapy
P D Ryan, B A Chabner
Cancer Chemotherapy and Biological Response Modifiers
|
January 1, 1990
Plant alkaloids
B A Chabner, S B Horwitz
Clinical Chemistry
|
August 1, 1996
Concepts in use of high-dose methotrexate therapy
S P Treon, B A Chabner
Page
of 25
Search research articles
Search
Showing results (21-30 of 245) with videos related to
Sort By:
Page
of 25
Science (New York, N.Y.)
|
May 14, 1993
Funding for gene therapy
B A Chabner, R Levy
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1991
Reversal of multidrug resistance
B A Chabner, W Wilson
Cancer Treatment Reports
|
July 1, 1977
Role of drug concentration, duration of exposure, and endogenous metabolites in determining methotrexate cytotoxicity
H M Pinedo, B A Chabner
Cancer Research
|
March 1, 1978
Pyrimidine nucleoside monophosphate kinase from human leukemic blast cells
K R Hande, B A Chabner
Analytical Biochemistry
|
January 1, 1980
A competitive protein binding assay for allopurinol and oxipurinol
K R Hande, B A Chabner
NCI Monographs : a Publication of the National Cancer Institute
|
January 1, 1986
National Institutes of Health Consensus Development Conference on Adjuvant Chemotherapy and Endocrine Therapy for Breast Cancer. Editorial overview
M E Lippman, B A Chabner
The New England Journal of Medicine
|
February 20, 1992
Progress against rare and not-so-rare cancers
B A Chabner, M A Friedman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2001
On receptor inhibitors and chemotherapy
P D Ryan, B A Chabner
Cancer Chemotherapy and Biological Response Modifiers
|
January 1, 1990
Plant alkaloids
B A Chabner, S B Horwitz
Clinical Chemistry
|
August 1, 1996
Concepts in use of high-dose methotrexate therapy
S P Treon, B A Chabner
Page
of 25